T-ALL leukemogenesis appears to be dependent on LMO2 activation triggered by SIRT2/NAMPT deactivation, a mechanism that generates increased stem cell hematopoiesis in the disease. The gene discussed is NAMPT; the disease is acute lymphoblastic leukemia.